Clinical Trial

The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

Name: The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus — clinical trial record (NCT06236022)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SDCMK

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

Evaluating the efficacy of sirolimus (compared to standard therapy alone) in the treatment of dilated cardiomyopathy infected with Kaposi Sarcoma-associated virus -- a multicenter randomized controlled study.

Trial Details

NCT Number	NCT06236022
Lead Sponsor	Tongji Hospital Collaborators: Wuhan Central Hospital, Wuhan Fourth Hospital, Wuhan University
Conditions	Dilated Cardiomyopathy, Kaposi's Sarcoma-Associated Herpesvirus Infection
Enrollment	276 participants
Start Date	2024-01-01
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-02-01